Artificial Eye Blinking Stimulation Following Paralysis of the Facial Nerve

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

November 1, 2021

Conditions
Facial ParalysisBell Palsy
Interventions
DEVICE

Neurotrigger eye blinking stimulator

"Phase 1 - The first stage is composed of a one-time participation for about three hours and involves:~1. Verifying compliance of the patients with the research inclusion and exclusion criteria~2. Completion of the study clinical report form (CRF) for this stage~3. Placement of the single use mini-electrodes that will be adhered to the facial skin near the non-blinking eye and coupled to the Neurotrigger stimulator to elicit eyelid closure.~Participants may be enrolled to the second phase up to one year from the first phase visit In the second stage the duration of the participation is about three weeks (six days a week) and includes daily use of the device for up to 10 hours a day. During nights the patient will continue is standard pattern of either eye closure or leaving the eye open, as the patient used to do prior to the study.~This stage will involve a patient with a partner that is designated to support the patient closely during the placement and adjustment of the system"

Trial Locations (1)

Unknown

Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Tel Aviv Medical Center

OTHER

lead

Neurotrigger Ltd

INDUSTRY

NCT04153916 - Artificial Eye Blinking Stimulation Following Paralysis of the Facial Nerve | Biotech Hunter | Biotech Hunter